RE
ABBV icon

RBC Europe’s AbbVie ABBV Stock Holding History

RBC Europe’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3.37M Sell
22,008
-105
-0.5% -$16K 0.16% 58
2022
Q1 		$3.58M Sell
22,113
-674
-3% -$97.9K 0.15% 63
2021
Q4 		$3.08M Sell
22,787
-7,475
-25% -$883K 0.14% 65
2021
Q3 		$3.26M Sell
30,262
-500
-2% -$57.1K 0.13% 86
2021
Q2 		$3.47M Buy
30,762
+375
+1% +$42.2K 0.16% 85
2021
Q1 		$3.29M Buy
30,387
+620
+2% +$66.3K 0.18% 83
2020
Q4 		$3.19M Sell
29,767
-324
-1% -$31.1K 0.18% 76
2020
Q3 		$2.64M Sell
30,091
-12,743
-30% -$1.2M 0.18% 80
2020
Q2 		$4.21M Buy
42,834
+344
+0.8% +$30.3K 0.33% 50
2020
Q1 		$3.24M Buy
42,490
+233
+0.6% +$19.8K 0.32% 54
2019
Q4 		$3.74M Buy
42,257
+330
+0.8% +$27.4K 0.33% 55
2019
Q3 		$3.17M Sell
41,927
-310
-0.7% -$21.3K 0.31% 57
2019
Q2 		$3.07M Buy
42,237
+30
+0.1% +$2.36K 0.31% 61
2019
Q1 		$3.4M Buy
42,207
+870
+2% +$71.2K 0.38% 54
2018
Q4 		$3.81M Hold
41,337
– – 0.5% 41
2018
Q3 		$3.91M Sell
41,337
-60
-0.1% -$5.69K 0.43% 48
2018
Q2 		$3.84M Sell
41,397
-2,955
-7% -$289K 0.45% 49
2018
Q1 		$4.2M Buy
44,352
+2,285
+5% +$251K 0.51% 45
2017
Q4 		$4.07M Sell
42,067
-10
-0% -$942 0.5% 44
2017
Q3 		$3.74M Buy
+42,077
New +$3.2M 0.49% 44

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe's ABBV Position: Q2 2022 in Review

RBC Europe reduced its AbbVie (ABBV) stake by 0.47% in Q2 2022, selling an estimated $16K and leaving 22,008 shares worth $3.37M. The position accounts for 0.16% of the portfolio, ranked #58.

RBC Europe first reported a position in ABBV in Q3 2017 and has held it in 20 quarters since. The position peaked at $4.21M in Q2 2020. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • RBC Europe held 22,008 shares of AbbVie worth $3.37M as of Q2 2022.
  • RBC Europe sold 105 AbbVie shares in Q2 2022, an estimated $16K.
  • AbbVie made up 0.16% of RBC Europe's portfolio in Q2 2022, its #58 holding.
  • RBC Europe first reported a position in AbbVie in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's AbbVie position peaked at $4.21M in Q2 2020.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.